POM121 is a Novel Marker for Predicting the Prognosis of Laryngeal Cancer

Overview

Journal Histol Histopathol

Specialties Anatomy & Histology
Pathology

Date 2020 Oct 5

PMID 33016327

Citations 7

Authors

Ruihua Zhao

Genxiong Tang

Tengqi Wang

Lingli Zhang

Wei Wang

Qiangfang Zhao

Kun Zhao

Affiliations

Soon will be listed here.

Abstract

The nuclear pore membrane protein 121 (POM121) is an important member of the nuclear pore complex which regulates nucleocytoplasmic transport, but little is known about the role of POM121 in laryngeal cancer. In this study, quantitative real-time polymerase chain reaction and immunohistochemistry were performed to detect POM121 expression in laryngeal tissues. The associations between POM121 and clinicopathological characteristics and overall survival in laryngocarcinoma patients were also analyzed. The mechanism of POM121 was preliminarily explored through gene set enrichment analysis (GSEA). mRNA and protein expression of POM121 in laryngocarcinoma tissues were higher than those in nontumor tissues. High POM121 expression was positively correlated with poor differentiation (χ²=42.391, P<0.001), advanced distant metastases (χ²=20.346, P<0.001) and TNM stage (χ²=23.436, P<0.001). Laryngocarcinoma patients with high POM121 level tended to have poor overall survival. GSEA confirmed that the mechanism of POM121 in laryngeal cancer may relate to sphingolipid metabolism, lysosome, fatty acid metabolism, ribosome, nucleotide excision repair and the PPAR signaling pathway. Overall, POM121 expression might be a prognostic biomarker in laryngeal cancer, and POM121 has the potential to present as a therapeutic target for laryngocarcinoma patients.

Citing Articles

Advances in the understanding of nuclear pore complexes in human diseases.

Li Y, Zhu J, Zhai F, Kong L, Li H, Jin X J Cancer Res Clin Oncol. 2024; 150(7):374.

PMID: 39080077 PMC: 11289042. DOI: 10.1007/s00432-024-05881-5.

Nuclear pore protein POM121 regulates subcellular localization and transcriptional activity of PPARγ.

Yu Y, Farooq M, Eberhart Meessen S, Jiang Y, Kato D, Zhan T Cell Death Dis. 2024; 15(1):7.

PMID: 38177114 PMC: 10766976. DOI: 10.1038/s41419-023-06371-1.

Therapeutic targeting of nuclear export and import receptors in cancer and their potential in combination chemotherapy.

Newell S, van der Watt P, Leaner V IUBMB Life. 2023; 76(1):4-25.

PMID: 37623925 PMC: 10952567. DOI: 10.1002/iub.2773.

Integrative analysis of circadian clock with prognostic and immunological biomarker identification in ovarian cancer.

Zhao L, Tang Y, Yang J, Lin F, Liu X, Zhang Y Front Mol Biosci. 2023; 10:1208132.

PMID: 37409345 PMC: 10318361. DOI: 10.3389/fmolb.2023.1208132.

POM121 promotes the proliferation and metastasis of gastric cancer via PI3K/AKT/MYC pathway.

Kang C, Jia L, Hao L, Zhang N, Liu Y, Zhang L Am J Cancer Res. 2023; 13(2):485-497.

PMID: 36895982 PMC: 9989611.

References

Vallee A, Lecarpentier Y . Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis. Front Immunol. 2018; 9:745. PMC: 5908886. DOI: 10.3389/fimmu.2018.00745. View

Antonin W, Franz C, Haselmann U, Antony C, Mattaj I . The integral membrane nucleoporin pom121 functionally links nuclear pore complex assembly and nuclear envelope formation. Mol Cell. 2005; 17(1):83-92. DOI: 10.1016/j.molcel.2004.12.010. View

Bui K, von Appen A, DiGuilio A, Ori A, Sparks L, Mackmull M . Integrated structural analysis of the human nuclear pore complex scaffold. Cell. 2013; 155(6):1233-43. DOI: 10.1016/j.cell.2013.10.055. View

Currie E, Schulze A, Zechner R, Walther T, Farese Jr R . Cellular fatty acid metabolism and cancer. Cell Metab. 2013; 18(2):153-61. PMC: 3742569. DOI: 10.1016/j.cmet.2013.05.017. View

Simon D, Rout M . Cancer and the nuclear pore complex. Adv Exp Med Biol. 2014; 773:285-307. DOI: 10.1007/978-1-4899-8032-8_13. View

Derenzini M, Montanaro L, Trere D . Ribosome biogenesis and cancer. Acta Histochem. 2017; 119(3):190-197. DOI: 10.1016/j.acthis.2017.01.009. View

Fortschegger K, Anderl S, Denk D, Strehl S . Functional heterogeneity of PAX5 chimeras reveals insight for leukemia development. Mol Cancer Res. 2014; 12(4):595-606. DOI: 10.1158/1541-7786.MCR-13-0337. View

Funakoshi T, Maeshima K, Yahata K, Sugano S, Imamoto F, Imamoto N . Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. FEBS Lett. 2007; 581(25):4910-6. DOI: 10.1016/j.febslet.2007.09.021. View

Geli V, Lisby M . Recombinational DNA repair is regulated by compartmentalization of DNA lesions at the nuclear pore complex. Bioessays. 2015; 37(12):1287-92. DOI: 10.1002/bies.201500084. View

10.

Ge W, Yue Y, Xiong S . POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. Exp Cell Res. 2019; 377(1-2):17-23. DOI: 10.1016/j.yexcr.2019.02.021. View

11.

Guo J, Liu X, Wu C, Hu J, Peng K, Wu L . The transmembrane nucleoporin Pom121 ensures efficient HIV-1 pre-integration complex nuclear import. Virology. 2018; 521:169-174. PMC: 6309762. DOI: 10.1016/j.virol.2018.06.008. View

12.

Chow K, Factor R, Ullman K . The nuclear envelope environment and its cancer connections. Nat Rev Cancer. 2012; 12(3):196-209. PMC: 4338998. DOI: 10.1038/nrc3219. View

13.

Kumar A, Sharma P, Gomar-Alba M, Shcheprova Z, Daulny A, Sanmartin T . Daughter-cell-specific modulation of nuclear pore complexes controls cell cycle entry during asymmetric division. Nat Cell Biol. 2018; 20(4):432-442. PMC: 6029668. DOI: 10.1038/s41556-018-0056-9. View

14.

Li L, Xu Y, Wang B . Liriodenine induces the apoptosis of human laryngocarcinoma cells via the upregulation of p53 expression. Oncol Lett. 2015; 9(3):1121-1127. PMC: 4314988. DOI: 10.3892/ol.2014.2834. View

15.

Lim K, Wong R . Targeting Nucleoporin POM121-Importin β Axis in Prostate Cancer. Cell Chem Biol. 2018; 25(9):1056-1058. DOI: 10.1016/j.chembiol.2018.09.003. View

16.

Lin X, Wen G, Wang S, Lu H, Li C, Wang X . Expression and role of EGFR, cyclin D1 and KRAS in laryngocarcinoma tissues. Exp Ther Med. 2019; 17(1):782-790. PMC: 6307426. DOI: 10.3892/etm.2018.7027. View

17.

Ma H, Li L, Jia L, Gong A, Wang A, Zhang L . POM121 is identified as a novel prognostic marker of oral squamous cell carcinoma. J Cancer. 2019; 10(19):4473-4480. PMC: 6746134. DOI: 10.7150/jca.33368. View

18.

Breuer M, Ohkura H . A negative loop within the nuclear pore complex controls global chromatin organization. Genes Dev. 2015; 29(17):1789-94. PMC: 4573852. DOI: 10.1101/gad.264341.115. View

19.

Marioni G . Letter to the editors: Essentials for an updated epidemiology of laryngeal carcinoma. Cancer Treat Rev. 2012; 38(6):559. DOI: 10.1016/j.ctrv.2012.02.005. View

20.

Marteijn J, Lans H, Vermeulen W, Hoeijmakers J . Understanding nucleotide excision repair and its roles in cancer and ageing. Nat Rev Mol Cell Biol. 2014; 15(7):465-81. DOI: 10.1038/nrm3822. View